肿瘤侧别对非小细胞肺癌放疗后生存的影响
该研究纳入1026例接受55 Gy/20次根治性放疗的非小细胞肺癌患者,比较左右侧肿瘤的生存差异。多变量分析显示右侧肿瘤总生存显著差于左侧(15个月对18个月,p<0.01),右肺平均剂量与总生存显著相关(p=0.03),左肺平均剂量无显著关联(p=0.78)。
要点
- 右侧非小细胞肺癌根治性放疗后总生存显著差于左侧(15对18个月)。
- 右肺平均剂量与总生存显著相关(p=0.03),左肺平均剂量无显著关联。
- 侧别效应可能源于左右肺剂量-反应差异,较大右肺对生存影响更大。
核心结论
- 右侧非小细胞肺癌接受根治性放疗后总生存显著差于左侧肿瘤。
- 侧别效应可能通过左右肺剂量-反应差异介导,右肺平均剂量对生存影响更大。
研究设计与样本
- 回顾性队列分析纳入1101例非小细胞肺癌患者,均接受55 Gy/20次根治性放疗。
- 最终1026例可评估,其中右侧肿瘤579例、左侧肿瘤447例。
- 通过比较肿瘤体积与肺的质心确定侧别,分割左右肺并计算平均剂量,纳入多变量Cox回归生存模型。
主要发现
- 多变量分析控制肿瘤体积(p<0.001)、年龄(p<0.001)、体能状态(p<0.05)和淋巴结分期(p<0.01)后,侧别仍高度显著(p<0.01)。
- 右侧肿瘤总生存为15个月,左侧肿瘤为18个月。
- 右肺平均剂量与总生存显著相关(p=0.03),左肺平均剂量无显著关联(p=0.78)。
临床怎么用
- 根治性放疗计划评估时,除总肺剂量外应关注右肺平均剂量对生存的潜在影响。
- 右侧非小细胞肺癌患者放疗预后可能较差,计划设计时需更重视右肺剂量限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lung cancer survival after radiotherapy remains poor and greater knowledge of normal tissue risk factors is needed to further optimise treatments. In this work, we investigate tumour laterality in a large cohort of patients treated with curative-intent radiotherapy, including the effect of dose on the right and left lungs. METHODS: 1101 NSCLC patients were included in the analysis, treated with 55 Gy in 20 fractions. Tumour laterality was determined by comparing the centre of mass of the tumour volume with the centre of mass of the lung. Right and left lungs were segmented from the whole lung contour and the mean dose to each volume calculated. Laterality and mean lung doses were included in multi-variable cox-regression survival models. RESULTS: 1026 patients were eligible for inclusion; 579 right-sided and 447 left-sided tumours were identified. All tumour and patient characteristics were balanced with laterality. The multi-variable models were controlled for known clinical factors: tumour volume (p < 0.001), age (p < 0.001), performance status (p < 0.05) and nodal stage (p < 0.01). Multi-variable analysis showed laterality to be highly significant (p < 0.01) with right-sided tumours showing worse overall survival than left-sided tumours (15 versus 18 months). The right lung mean dose was found to be significant (p = 0.03) for overall survival but the left lung mean dose was not (p = 0.78). CONCLUSION: Our study showed that right-sided lung tumours show worse overall survival for NSCLC treated with curative-intent radiotherapy. Results suggest that the effect of laterality is through a difference in dose-response for individual lungs, with the larger, right lung, having the greater impact on survival.
引用
- McWilliam A, Vasquez Osorio E, Faivre-Finn C, et al. Influence of tumour laterality on patient survival in non-small cell lung cancer after radiotherapy. Radiother Oncol. 2019. PMID: 31078940. doi:10.1016/j.radonc.2019.04.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。